Anonymous
Guest
Anonymous
Guest
So, you are finally admitting that Riemser/Curasan missed the boat once again on TCP. Yes, there are at least a dozen companies making millions selling generic Allografts and Riemser isn't one of them. Riemser actually has ok products; They could probably compete with the companies making millions, but its too little, too late. What does that tell you? It tells you that this company has been horribly mismanaged for many years. Riemser is not fine - its struggling to stay in business.
This statement does make sense. I used to see Cerasorb everywhere during my surgical calls. I haven't seen it anywhere lately and in fact I see those docs using other grafts now.